Scarica l'app Stockscreener
148.12
1.24%
1.82
Dopo l'orario di chiusura:
147.80
-0.32
-0.22%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$146.30
Aprire:
$147.63
Volume 24 ore:
3.48M
Relative Volume:
1.59
Capitalizzazione di mercato:
$35.35B
Reddito:
$222.29B
Utile/perdita netta:
$1.56B
Rapporto P/E:
23.11
EPS:
6.41
Flusso di cassa netto:
$2.44B
1 W Prestazione:
-5.42%
1M Prestazione:
-7.98%
6M Prestazione:
+16.83%
1 anno Prestazione:
+44.39%
Intervallo 1D:
$145.47
$148.76
Intervallo di 1 settimana:
$137.75
$159.41
Portata 52W:
$105.01
$168.44
Cardinal Health Inc Stock (CAH) Company Profile
Nome
Cardinal Health Inc
Settore
Industria
Telefono
(614) 757-3033
Indirizzo
7000 CARDINAL PLACE, DUBLIN, OH
Confronta CAH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CAH
Cardinal Health Inc
|
148.12 | 34.92B | 222.29B | 1.56B | 2.44B | 6.41 |
|
MCK
Mckesson Corporation
|
663.17 | 81.97B | 377.60B | 3.16B | 5.67B | 25.08 |
|
COR
Cencora Inc
|
291.04 | 56.06B | 316.65B | 1.90B | 1.14B | 9.72 |
|
HSIC
Henry Schein Inc
|
68.99 | 8.02B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.77 | 689.96M | 2.22M | -5.63M | -1.68M | -0.24 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-03 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-01-08 | Aggiornamento | TD Cowen | Hold → Buy |
| 2025-01-07 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-01-06 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-12-13 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | Ripresa | Mizuho | Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-09 | Aggiornamento | Argus | Hold → Buy |
| 2024-01-03 | Iniziato | Barclays | Overweight |
| 2023-12-14 | Iniziato | Wells Fargo | Underweight |
| 2023-07-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-03-31 | Iniziato | Citigroup | Neutral |
| 2023-02-03 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-08-22 | Ripresa | Morgan Stanley | Overweight |
| 2022-05-26 | Downgrade | Barclays | Overweight → Equal Weight |
| 2022-05-18 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-04-12 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2021-08-06 | Downgrade | Deutsche Bank | Buy → Hold |
| 2021-08-05 | Downgrade | BofA Securities | Buy → Underperform |
| 2021-05-10 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | Aggiornamento | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2020-09-25 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2020-07-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-15 | Aggiornamento | UBS | Neutral → Buy |
| 2020-04-23 | Ripresa | Credit Suisse | Neutral |
| 2020-03-20 | Aggiornamento | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-09-12 | Iniziato | Deutsche Bank | Hold |
| 2019-08-27 | Downgrade | Argus | Buy → Hold |
| 2019-08-20 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2019-04-18 | Iniziato | Guggenheim | Neutral |
| 2019-01-17 | Iniziato | UBS | Neutral |
| 2018-11-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-03-08 | Iniziato | Barclays | Equal Weight |
| 2018-02-27 | Ripresa | BofA/Merrill | Underperform |
| 2018-01-05 | Iniziato | Evercore ISI | In-line |
Mostra tutto
Cardinal Health Inc Borsa (CAH) Ultime notizie
Cardinal Health Starts High-Grade Bond Sale to Fund Solaris Deal - Bloomberg.com
Cardinal Health (CAH) Falls on Dismal Revenue Performance - MSN
Deutsche Bank Adjusts Cardinal Health Price Target to $176 From $163 - MarketScreener
Cardinal Health Offers $1 Billion of Bonds for Solaris Deal - Yahoo Finance
Market Tremors: Cava Group, CoreWeave, Kroger, and Cardinal Health Inc. Face Significant Declines - FinancialContent
Cardinal Health starts high-grade bond sale to fund Solaris deal - Crain's Cleveland Business
Cardinal Health to Sell Bonds to Help Fund $1.9 Billion Solaris Health Acquisition - MarketScreener
Cardinal Health: $1.9 Billion Deal For Solaris Health - Pulse 2.0
Form 424B3 CARDINAL HEALTH INC - StreetInsider
Cardinal Health, Inc. (NYSE:CAH) Q4 2025 Earnings Call Transcript - Insider Monkey
Citigroup Adjusts Price Target on Cardinal Health to $165 From $170, Maintains Neutral Rating - MarketScreener
Baird Adjusts Price Target on Cardinal Health to $203 From $197, Maintains Outperform Rating - MarketScreener
Cardinal Health to acquire Solaris Health for USD 1.9 billion in cash - Medical Buyer
Cardinal Health Inc (CAH) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Contract Challenges - GuruFocus
Cardinal Health 2025 Q4 Earnings Strong Performance as Net Income Surges 4.3% - AInvest
Cardinal Health Reports Strong Q4 and FY 2025 Results - TipRanks
Decoding Cardinal Health Inc (CAH): A Strategic SWOT Insight - GuruFocus
Cardinal Health (CAH) Tops Q4 Earnings Estimates - MSN
Cardinal Health Sells Bonds To Back Solaris Health Deal - Finimize
Cardinal Health to buy Solaris Health for $1.9 billion, posts weak results - ET HealthWorld
Cardinal Health’s Strong Performance and Strategic Initiatives Justify Buy Rating - TipRanks
Cardinal Health to Extend Reach by Acquiring Solaris Health - PYMNTS.com
Why Cardinal Health Stock Was Tumbling on Tuesday - AOL.com
Lee Equity Partners exits Solaris Health in $1.9B sale to Cardinal Health - PitchBook
New Customers, Solid Prescription Trend, and Growing Specialties Support Cardinal's Long-Term Growth - Morningstar
Cardinal Health Reports Flat 4Q Revenue, Higher Profit and a $1.9B Acquisition - Modern Distribution Management
Despite Profit Surge, Cardinal Health Shares Tumble on Revenue Shortfall - FinancialContent
Ohio giant Cardinal Health makes $1.9 billion urology deal - Crain's Cleveland Business
JPMorgan Adjusts Price Target on Cardinal Health to $178 From $175 - MarketScreener
Cardinal Health Q4 Earnings Beat Estimates, Revenue Hits $60.16BNews and Statistics - IndexBox
Cardinal Health Q4 2025 Earnings Call Transcript - MarketBeat
Cardinal Health, Inc. ($CAH) Stock: Shares Drop as Revenue Misses Despite Raised Outlook and $1.9B Solaris Deal - CoinCentral
Cardinal Health price target lowered to $186 from $188 at Leerink - TipRanks
Evercore ISI Cuts Price Target on Cardinal Health to $190 From $200 - MarketScreener
Leerink Partners Adjusts Price Target on Cardinal Health to $186 From $188 - MarketScreener
Mixed Fortunes: Chipotle Sizzles on Upgrades, Cardinal Health Stumbles Despite Profit Beat - FinancialContent
Cardinal Health expands urology focus with $1.9bn Solaris Health deal - Yahoo Finance
Cardinal Health (CAH) Reports US$1,561 Million Net Income With Strong Earnings Per Share Growth - simplywall.st
Cardinal Health to Acquire Solaris in $1.9B Deal - USA Herald
Sea, Cardinal Health, Circle, and On Holding: Here are the stocks moving this morning - MSN
Cardinal Health To Provide $1.9B To Specialty Alliance Division To Enable Solaris Health Acquisition: More Details Inside - Stocktwits
Cardinal Health commits $1.9 billion cash for deal to buy Solaris Health - kdal610.com
Zacks Industry Outlook Highlights McKesson, Cardinal Health, West Pharmaceutical Services and The Cooper Companies - The Globe and Mail
Cardinal Health Reports Q4 2025 Financial Results - TipRanks
3 Firms Advise As Cardinal Health Makes $1.9B Urology Push - Law360
Cardinal Health Boosts Specialty Presence With Solaris Health Acquisition, Lifts Profit Outlook - AOL.com
Intel CEO meets with Trump, Cardinal Health to acquire Solaris: Morning Buzz - TipRanks
Cardinal Health profit nearly doubles in FY25 despite flat salesColumbus Business First - The Business Journals
Transcript : Cardinal Health, Inc., Q4 2025 Earnings Call, Aug 12, 2025 - MarketScreener
Top Stock Movers Now: Hanesbrands, On Holding, Cardinal Health, and More - Investopedia
Contradictions Unveiled: Analyzing Cardinal Health's Q4 2025 Earnings Call Insights on Tariffs and Pharma Growth - AInvest
Cardinal Health Inc Azioni (CAH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.65%
4.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):